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Caspase-8 deficiency in certain cells prompts
chronic inflammation. One mechanism suggested
to account for this inflammation is enhanced sig-
naling for necrotic cell death, mediated by the protein
kinases RIPK1 and RIPK3 that caspase-8 can cleave.
We describe an activity of caspase-8 in dendritic
cells that controls the initiation of inflammation in
another way. Caspase-8 deficiency in these cells
facilitated lipopolysaccharide-inducedassembly and
function of the NLRP3 inflammasome. This effect
depended on the functions of RIPK1 and RIPK3,
as well as of MLKL and PGAM5, two signaling
proteins recently shown to contribute to RIPK3-
mediated induction of necrosis. However, although
enhancement of inflammasome assembly in the
caspase-8-deficient cells shares proximal signaling
events with the induction of necrosis, it occurred
independently of cell death. These findings provide
new insight into potentially pathological inflamma-
tory processes to which RIPK1- and RIPK3-medi-
ated signaling contributes.
INTRODUCTION
The caspases are evolutionarily conserved cysteine proteases
that cleave specific substrate proteins downstream of aspartate
residues. They were initially known for two physiological func-
tions: induction of inflammation by the processing of precursors
of proinflammatory cytokines such as IL-1b, an activity mediated
by caspase-1 and some other ‘‘proinflammatory caspases,’’ and
induction of apoptotic cell death. The latter function is triggered
by a number of ‘‘initiator caspases’’ that are activated through
interaction of their N-terminal ‘‘prodomain’’ with a distinct
upstream receptor complex. However, for such activation to
lead to cell death, the initiator caspases must first cleave and
thus activate other caspases (‘‘effector caspases’’) that lack pro-
domains. These in turn cleave a wide range of specific cellular
proteins, thereby triggering the apoptotic program (reviewed in
(Riedl and Shi, 2004)). Cells possess mechanisms that can
restrict the function of initiator caspases in a way that withholds
massive activation of other caspases. Recent findings showed
that when the initiator caspases act in this restricted manner,they can initiate additional, nonapoptotic functions (van Raam
and Salvesen, 2012).
Caspase-8 was originally identified as an initiator of apoptotic
cell death in response to death-inducing TNF family receptors, to
which it is recruited by binding to the adaptor protein FADD (also
known as MORT1) (Boldin et al., 1996; Muzio et al., 1996). It was
later found to serve a variety of other functions as well (Ben
Moshe et al., 2008; Kang et al., 2004; Varfolomeev et al.,
1998). Notably, in several transgenic mouse models, its defi-
ciency results in chronic inflammation (Ben Moshe et al., 2007;
Kovalenko et al., 2009; Wallach et al., 2010), suggesting
that besides inducing apoptotic cell death caspase-8 also
restricts the signaling for some inflammatory mechanisms. In
the attempt to identify the signaling molecules whose activity is
restricted by caspase-8, it was found that the inflammation
and embryonic death resulting from caspase-8 deficiency
involve two structurally related protein kinases, RIPK1 and
RIPK3 (Duprez et al., 2011; Kaiser et al., 2011; Oberst et al.,
2011). These findings were consistent with reports that exces-
sive activation of these two protein kinases results in inflamma-
tion and might play important roles in various pathological
processes (Cho et al., 2009; Degterev et al., 2005; Duprez
et al., 2011; He et al., 2009; Mocarski et al., 2012; Smith et al.,
2007; Zhang et al., 2009).
Ex vivo studies showed that excessive activation of RIPK1 and
RIPK3 might result in necrotic cell death (Hitomi et al., 2008;
Holler et al., 2000; Oberst et al., 2011). A series of molecular
events contributing to the induction of such death was recently
disclosed: RIPK1 phosphorylates and thus activates RIPK3
(Cho et al., 2009; He et al., 2009; Zhang et al., 2009). The latter
phosphorylates the protein kinase homolog MLKL and the
protein phosphatase PGAM5 (Sun et al., 2012; Wang et al.,
2012; Zhao et al., 2012). PGAM5 can activate the mitochondrial
fission factor Drp1 and the resulting derangement of mitochon-
drial function probably contributes to the necrotic death of the
cells (Wang et al., 2012). It was suggested that the inflammation
caused by caspase-8 deficiency in vivo is mediated by proin-
flammatory cellular components that are released when cells
die by necrosis as a result of this deficiency (reviewed in (Wallach
et al., 2011)). Here we describe an additional functional conse-
quence of caspase-8 deficiency that is likely also to contribute
to inflammation. Dendritic cells (DCs) deficient in caspase-8
are shown to be hyperresponsive to induction of assembly of
the NLRP3 inflammasome, a signaling complex that, through
activation of caspase-1, mediates processing of the precursors
for proinflammatory mediators such as IL-1b (Schroder andImmunity 38, 27–40, January 24, 2013 ª2013 Elsevier Inc. 27
Figure 1. Caspase-8 Deficiency in Dendritic Cells Facilitates LPS-Induced Increase in Serum IL-1b and Death in Mice in a Way that Depends
on RIPK1 and RIPK3 Function
(A–C) Survival of WT mice and of C8 mice after injection of LPS (5 mg/kg). (A) and (C) show comparison of the above to the lethal effect of LPS on WT mice
injected with LPS (5 mg/kg) together with D-galactosamine (GalN, 800 mg/kg). (A) shows comparison of the effects of IL-1RA (25 mg/kg) and of TNF antibody
(50 mg) on survival. (C) shows comparison of the histology (H&E staining, top) of livers in C8 andWTmice at the time of death and of the extents of apoptotic cell
(legend continued on next page)
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the enhanced activation of the inflammasome as a result of cas-
pase-8 deficiency depends on the functions of RIPK1, RIPK3,
MLKL, and PGAM5. This activation, however, occurs indepen-
dently of cell death.
RESULTS
Deletion of Casp8 from Dendritic Cells Facilitates
LPS-Induced Generation of IL-1b In Vivo
To investigate the functional roles of caspase-8 in DCs, we
generated mice with specific deficiency of caspase-8 in these
cells (Casp8fl/:Itgax-Cre mice; ‘‘C8 mice’’). The mice were
born with normal Mendelian segregation and appeared to
develop normally. However, their responses to various patholog-
ical challenges revealed that they display greatly enhanced
vulnerability to the lethal effect of injected bacterial endotoxin
(lipopolysaccharide [LPS]; Figures 1A and 1B). Unlike in the
widely used galactosamine-sensitization model (Galanos et al.,
1979), in which mice can be protected from the lethal effect of
a low dose of injected LPS by blocking of TNF-induced liver
damage but not by blocking IL-1, death of the C8 mice after
LPS injection was not associated with liver damage (Figure 1C;
see also Figure S1 available online) and was not affected by
injection of TNF antibody but could be prevented by the injection
of IL-1 receptor antagonist (IL-1RA; Figure 1A). Examination of
the sera of the LPS-injected mice showed that the increase in
IL-1b in these mice was much higher than in wild-type (WT)
mice (Figure 1D). In contrast, induction of TNF by LPS was mini-
mally affected by a caspase-8 deficiency at the time of peak TNF
elevation, though at later times it was higher than in WT mice
(Figure 1E). Injection of IL-1RA decreased the serum concentra-
tions of both IL-1b and TNF (Figures 1F and 1G).
We assessed the involvement of RIPK1 and RIPK3 in the
enhanced response of the C8mice to LPS and found that injec-
tion of necrostatin-1 (Nec1), an inhibitor of RIPK1 kinase function
(Degterev et al., 2008), delayed the lethal effect of LPS (Figure 1B)
and suppressed both the excessive induction of IL-1b and the
later excessive increase in TNF (Figures 1H, 1I). Moreover, on
RIPK3-deficient background, caspase-8 deficiency in the DCs
did not result in enhanced vulnerability to LPS (Figure 1B) or in
an enhanced LPS-induced increase in serum IL-1b or TNF
(Figures 1J and 1K).
Anatomical and histological analyses revealed complex
cellular changes in the lymphoid systems of these mice. In
both the RIPK3-expressing and the RIPK3-deficient C8 mice,
spleens and lymph nodes were greatly enlarged. However, the
cellular basis for these size increases differed. In the mice ex-
pressing RIPK3, the increased spleen size (Figure 2A; Fig-
ure S2A) was not associated with a gross change in splenic mi-
croarchitecture (Figure 2B). It was also not associated with an
overall increase in cell number (Figure 2C), although an increasedeath (arrows) in them (TUNEL staining, bottom; NT, not treated). In all histologic
(6.25 mg/kg) and of ubiquitous deficiency in RIPK3.
(D–K) Serum IL-1b and TNF levels after LPS injection in mice of the indicated gen
them. Unless otherwise indicated, sera were collected 3 hr after LPS injection
independent experiments. In all diagrams, values correspond tomean values and
the sera obtained from three mice.in number was seen in some specific cells, including stromal
cells (Figure 2D), erythrocytes (Figure 2E), and several kinds of
myeloid cells (Figures 2F and 2G, also see Figures S2B–S2D).
The increase in spleen size was apparently due to a marked
increase in the spleen’s collagen content (Figure S2E). In
contrast, in Ripk3 null mice the increase in spleen size as a result
of caspase-8 deficiency in the DCs (Figure 2H; Figure S2A) was
associated with altered microarchitecture and a marked
increase in cell number of the lymphoid organs when the mice
grew older (Figures 2I and 2J), resulting from accumulation of
CD4CD8CD3+ B220+ T lymphocytes (Figures 2K and 2L;
Figures S2F–S2H). These lymphocytes were found, like the
DCs, to be deficient in caspase-8 (Figures S2I and S2J). Accu-
mulation of such caspase-8-deficient cells in C8 mice, whose
Casp8 deletion was dictated by their mating to a mouse strain
expressing Cre under control of the Itgax (CD11c) promoter, is
consistent with the reported expression of the latter transgene
(though only in a proportion of the cells) in several leukocyte
types in addition to DCs, including T lymphocytes (Caton et al.,
2007). It is also consistent with studies showing that CD4
CD8CD3+ B220+ T lymphocytes accumulate in mice with
T cell-specific or ubiquitous deficiency of caspase-8 on a
Ripk3 null background (Kaiser et al., 2011; Oberst et al., 2011).
Results of bromodeoxyuridine labeling tests in vivo suggested
that caspase-8 deficiency in DCs led to an enhanced turnover of
these cells in the spleen (Figure S2K). However, whereas their
numbers in the lymph nodes were found to increase, their
amounts in the spleen remained unchanged (Figure S2D).
The enhanced induction of IL-1b by LPS observed in the C8
mice might reflect a direct impact of caspase-8 deficiency on
IL-1b generation by these cells. Alternatively, it could be an indi-
rect consequence of the complex cellular changes observed in
these mice. To determine which of these two possibilities is
correct, we examined the effect of caspase-8 deletion in DCs
ex vivo on the generation of IL-1b in these cells.
LPS Treatment Triggers IL-1b Secretion by Caspase-8-
Deficient Dendritic Cells in Culture
Casp8 was effectively deleted in bone-marrow progenitor cells
of C8 mice when the cells were induced (by culturing with
GM-CSF) to differentiate to DCs (Figure S3). The regulation of
IL-1b generation in the caspase-8-deficient cells appeared to
be different from that in the WT. Normally, induction of IL-1b
secretion by cultured DCs requires their exposure to dual stimu-
lation, first by a priming agent thought to trigger the synthesis of
several proteins that participate in this process, and then by an
activating agent. LPS usually exerts only the priming effect,
and further stimulation must be provided by an activating agent
such as ATP. However, DCs that were rendered deficient in cas-
pase-8 also produced IL-1b in response to LPS treatment alone
(although less effectively than when treated with a combination
of LPS and ATP) (Figures 3A and 3B). The same was found foral images, the scale bars correspond to 200 mM. (B) shows the effect of Nec1
otypes, and the effects of IL-1RA (F and G) and of Nec1 (H and I) injection on
. All data presented in this article are representative results of at least three
error bars showSD. Each of the bars in (F)–(K) corresponds to themean value in
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Figure 2. Impact of Caspase-8 Deficiency in Dendritic Cells on Leukocyte Levels and its Modulation by RIPK3
(A–G) Experiments in WT and C8mice (10 weeks old) expressing RIPK3 as follows: (A) spleen weight; (B) spleen histology (H&E staining), showing conservation
of normal spleen architecture in the C8 spleen; WP, white pulp; RP, red pulp; (C) spleen cell counts.
(D–G) FACS analysis of various cell types as follows: (D) stromal cells (CD45); (E) relative proportions of erythrocytes (Ter119+); (F) granulocytes (Ly6G+); (G)
myeloid cells expressing CD11b and Gr1.
(H–L) Experiments in Ripk3/ and C8 Ripk3/mice (10 and 20 weeks old) as follows: (H) spleen weight; (I) spleen histology at 20 weeks, showing distortion of
the parenchymal architecture due tomarked expansion of thewhite pulp as a result of accumulation of less heavily stained cells (blasts); (J) total spleen cell count.
(K) CD3+ B220+ cells in the spleen; (L) representative FACS cytogram of CD3 and B220 expression pattern in splenocytes and lymph node cells at 20 weeks. No
consistent change in amount of any other leukocyte type could be observed in the C8 Ripk3/ mice.
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TNF and IL-6, two cytokines whose secretion can be induced
even in WT DCs merely by treatment with LPS, was not affected
by caspase-8 deficiency (Figures 3D and 3E).
DCs derived from WT bone-marrow cells in which caspase-8
had been knocked down by small-interfering RNA (siRNA) treat-
ment also produced increased amounts of IL-1b in response to
stimulation with LPS alone (Figure 3F).
Besides LPS, several other pathogen-derived compounds
known to prime DCs for IL-1b generation also induced, indepen-
dently of an activating agent, IL-1b generation in the caspase-8-
deficient DCs but not in the normal cells (Figure 3G).
Nec1 effectively blocked IL-1b induction in the C8 cells by
LPS as well as by other pathogen-derived compounds (Fig-
ure 3G) but did not affect its induction by combined treatment
with LPS and ATP (Figure 3H) or the generation of TNF by
either the WT or the mutant cells (Figure 3I). DCs deficient in
both caspase-8 and RIPK3 did not produce IL-1b in response
to LPS (Figure 3J).
Thus, the enhanced generation of IL-1b that occurs as a result
of caspase-8 deficiency in the DCs is not secondary to the
complex cellular changes imposed by this deficiency in vivo
but reflects a direct impact of caspase-8 on the functions of
RIPK1 and RIPK3 within these cells.
Treatment of Caspase-8-Deficient Dendritic Cells
with LPS Alone Activates the Inflammasome
The need for dual stimulation to generate IL-1b in DCs is due to
participation of two distinct groups of mechanisms in this
process. Priming of the cells initiates the synthesis of cyto-
plasmic IL-1b precursor molecules (pro-IL-1b) and some of the
molecules required for their maturation. Activation of the cells
triggers the assembly of ‘‘inflammasomes’’—macromolecular
complexes in which pro-caspase-1 is activated by self-process-
ing, allowing caspase-1 to process the pro-IL-1b molecules.
Activation of the inflammasome is coupled to IL-1b secretion
from the cells by an unknown mechanism (Schroder and
Tschopp, 2010).
We quantified the pro-IL-1b transcripts and protein and found
that both were low in caspase-8-deficient DCs, just as they were
inWT cells, and that the transcription and translation of pro-IL-1b
were induced by LPS to the same extent in both (Figures 4A and
4B). In both C8 and WT cells, LPS also induced a similar mild
increase in NLRP3, a component of the inflammasome that
participates in IL-1b induction by LPS (Figure 4B). These findings
suggest that the greater production of IL-1b by the caspase-8-
deficient cells does not reflect enhanced synthesis of the
proteins mediating this process.
Production of the proteolytically processed, active form of
caspase-1 occurred in the WT DCs only after their combined
treatment with LPS and ATP. In contrast, in caspase-8-deficient
cells accumulation of the active form of the enzyme was induced
by treatment with LPS alone (Figure 4C). Consistent with this
observation, LPS alone was sufficient to induce the caspase-
8-deficient but not the WT cells to secrete the proteolytically
processed IL-1b generated by the active form of caspase-1
(Figure 4D). These findings implied that in cells deficient in
caspase-8, LPS induces not only the synthesis of pro-IL-1b but
also activation of the enzyme that cleaves it—a process that inthe WT cells is mediated by the NLRP3 inflammasome. As with
the generation of IL-1b in WT cells, its generation in the cas-
pase-8-deficient DCs in response to LPS alone was decreased
when NLRP3 or ASC (an adaptor protein that associates with
NLRP3 and caspase-1 within the inflammasome) was knocked
down (Figures 4E–4G), suggesting that here too IL-1b process-
ing is mediated by the inflammasome.
Further evidence for the induced assembly of these proteins
came from our finding that treatment of caspase-8-deficient
DCs with LPS, as well as treatment of caspase-8-expressing
cells with LPS+ATP (though not with LPS alone), resulted in
assembly of ASC and caspase-1 into a form that could not be
extracted with a solution containing 1% of the detergent NP40.
Nec1 treatment blocked such assembly when it was induced
by LPS in the caspase-8-deficient cells, but did not affect that
induced by LPS+ATP (Figure 4H). LPS also induced assembly
of some NLRP3 into a detergent-insoluble form. However, the
portion of NLRP3 converted to an insoluble formwasmuch lower
than that of ASC (not shown).
Part of the caspase-1 that accumulated in the detergent-insol-
uble fraction was the mature, proteolytically processed form,
suggesting that the protein interactions occurring within this
fraction correspond to the functional inflammasome (Figure 4H).
Consistently with this notion, we found that the inflammasome
components within this fraction could be crosslinked to each
other with the aid of a reversible short chemical linker (Figure 4I).
They could also be crosslinked when we applied the crosslinking
agent to intact DCs in which IL-1b generation was induced
(Figure S4A).
We previously reported that caspase-8 deficiency facilitates
induction of interferon and other IRF3-dependent genes by the
RIG-I signaling complex (Rajput et al., 2011). Induction of such
genes by LPS in the DCs was not enhanced by caspase-8 defi-
ciency (Figure S4B). Moreover, neither application of interferon
nor blocking of interferon function had any effect on the LPS-
induced production of IL-1b by these cells (Figures S4C and
S4D), ruling out an autocrine interferon effect on the enhanced
production of IL-1b by the caspase-8-deficient DCs.
Enhancement of InflammasomeActivationbyCaspase-8
Deficiency Does Not Reflect Increased Generation of
Extracellular Activating Molecules
One way that caspase-8 deficiency in the DCs could obviate the
need for activating agents such as ATP to induce IL-1b genera-
tion is by inducing generation of such activating agents by the
DCs themselves. This possibility seemed plausible in view of
prior evidence that caspase-8 deficiency facilitates necrotic
cell death (Holler et al., 2000; Oberst et al., 2011) and extensive
evidence that this form of cell death can result in release of
cellular components capable of triggering inflammation (Rock
and Kono, 2008).
To explore the interrelationship between the induction of
necrotic cell death and the induction of IL-1b generation in the
caspase-8-deficient DCs, we determined the kinetics of IL-1b
generation in the DCs and their viability after application of
LPS, as well as in response to several other agents previously
shown to facilitate RIPK3-mediated necrosis, namely TNF, the
pan-caspase inhibitor z-VAD, and BV6, an inhibitor of cIAP1
and cIAP2. Assessment of DC viability by a number of differentImmunity 38, 27–40, January 24, 2013 ª2013 Elsevier Inc. 31
Figure 3. Caspase-8-Deficient Dendritic Cells Secrete IL-1b and IL-18 in Response to Treatment with Priming Agents Only, in a RIPK1- and
RIPK3-Dependent Manner
(A–E) Secretion of the indicated cytokines byDCsderived in vitro frombone-marrowprogenitor cells ofWTandC8mice in response either to LPSor to LPS+ATP.
(F) Knockdown of caspase-8 in WT DCs. Left shows the effect of the knockdown on generation of IL-1b in response to LPS; right shows the expression of
caspase-8 mRNA in the knocked-down cells.
(G) Secretion of IL-1b in response to the indicated inducers (which in this experiment were applied for 6 hr) and the effect of added Nec1.
(legend continued on next page)
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potential revealed no sign of enhanced death in the caspase-
8-deficient DCs 3 hr after LPS application, by which time the
extent of IL-1b generation was already maximal (Figures 5A
and 5B; Figures S5A–S5D). Initial signs of minor induction of
cell death could be discerned in these cells only about 24 hr after
application of LPS (Figure 5B).
Treatment of the caspase-8-deficient cells with TNF and BV6
together (but not separately) also resulted in induction of IL-1b,
with no sign of cell death as late as 24 hr after application
(Figures 5C and 5D). However, both LPS treatment and treat-
ment with TNF+BV6, when supplemented with the pan-caspase
inhibitor z-VAD, did result in cell death, which was associated
with release of unprocessed IL-1b (Figures 5A–5D; Figure S5E).
The generation of IL-1b in response to each of these inducers
was proportional to the extent of assembly of the NLRP3 inflam-
masome as assessed by the tests described above (Figure 5E).
Altogether, these findings implied that although the agents
inducing inflammasome assembly in the caspase-8-deficient
cells can, under some conditions, also induce necrotic cell
death, the former effect is exerted independently of the latter.
It has been suggested that reactive oxygen species (ROS),
generated in response to RIPK3 activation, contribute to the
induction of necrotic cell death. ROS were also suggested to
activate the NLRP3 inflammasome. However, althoughwe found
some enhancement of ROS generation by LPS in the DCs, this
increase was not affected by caspase-8 deficiency or by
z-VAD treatment. In cells treated with TNF+BV6, we found that
z-VAD did increase ROS generation to some extent, but no effect
on ROS generation was exerted by caspase-8 deficiency either
in the presence or in the absence of z-VAD (Figure 5F).
Several additional points of evidence further negate the
involvement of either necrotic cell death or cellular components
released from dying cells in the enhanced generation of IL-1b by
the caspase-8-deficient cells. Lysates of DCs generated by their
freezing and thawing—an approach widely applied to reproduce
the generation of inflammatory components of cells during
necrotic death—had no effect on IL-1b generation in our test
system (Figure 5G). Whereas application of ATP to DCs induced
generation of cell-membrane pores (Nihei et al., 2000; Virginio
et al., 1999), as reflected in dramatic enhancement of ethidium
bromide uptake, treatment with LPS caused minimal uptake
either in the caspase-8-deficient or in the WT cells (Figure 5H),
excluding a greater impact of endogenously generated ATP
(Corriden and Insel, 2010; Piccini et al., 2008) on the former cells.
Neither the amounts of ATP that accumulated in the caspase-8-
deficient DC cultures nor the extent of their increase by LPSwere
any greater than those observed in the WT cultures (Figure 5I). In
cocultures of caspase-8-expressing and caspase-8-deficient
DCs, the amounts of IL-1b induced by LPS were identical to
those produced by the caspase-8-deficient DCs when cultured
alone (Figure 5J).
These findings indicated that the obviation of need for an acti-
vating agent such as ATP to induce IL-1b in DCs deficient in cas-(H and I) Effect of Nec1 on secretion of IL-1b in response to LPS + ATP and on s
(J) Secretion of IL-1b by DCs derived from the indicated mouse strains in r
experiments LPS was applied for 3 hr at 1 mg/ml and ATP (5 mM) was applied fo
wells.pase-8 does not reflect generation of some extracellular medi-
ator that acts similarly to ATP, but rather the stimulation of
some cell-autonomous intracellular mechanisms that activate
the inflammasome.
Signaling Mechanisms Mediating the Induction of
NLRP3 Inflammasome Assembly in C8– Cells
Induction of necrosis through RIPK3 activation is initiated by the
assembly of a signaling complex containing RIPK1 and RIPK3
(the ‘‘ripoptosome’’ or ‘‘necrosome’’). This assembly is counter-
acted by caspase-8, which associates with this complex along
with the adaptor protein FADD (MORT1). Consistent with prior
evidence that stimulation of the Toll-like receptor (TLR), as well
as treatment with TNF in the presence of an IAP inhibitor, can
trigger ripoptosome assembly (Feoktistova et al., 2011; He
et al., 2011; Vanlangenakker et al., 2011), we found that treat-
ment of the DCs with LPS (which acts by triggering TLR4
signaling), or with TNF+BV6, induced association of both
RIPK1 and RIPK3 with FADD and that this association was
largely dependent on the absence of caspase-8 (Figure 6A,
6B). Consistent with a role of caspase(s) in arresting the
assembly of this complex, the amounts of RIPK3 that could be
coimmunoprecipitated with caspase-8 from lysates of cells stim-
ulated by LPS or TNF+BV6 increased markedly when caspase
function in these cells was blocked by z-VAD (Figures 6C
and 6D).
The ripoptosomewas suggested to signal for necrosis through
sequential activation of MLKL and PGAM5 (Sun et al., 2012;
Wang et al., 2012; Zhao et al., 2012). The death induced in
DCs by combined treatment with LPS and z-VAD was indeed
markedly reduced by knockdown of MLKL, and marginally also
by knockdown of PGAM5 (Figure 6E). Induction of IL-1b by
LPS in caspase-8-deficient cells was likewise decreased by
knockdown ofMLKL andwas also strongly decreased by knock-
down of PGAM5 (Figure 6F). Thus, even though it occurs inde-
pendently of necrotic cell death, induction of inflammasome acti-
vation in the caspase-8-deficient DCs seems to involve several
of the proximal signaling proteins known to mediate induction
of necrotic death.
A surprising finding was that LPS treatment also induced
association of both FADD and caspase-8 with NLRP3 (Figures
6H and 6I). This raised the possibility that in addition to suppress-
ing the signaling by the ripoptosome for generation of the inflam-
masome, caspase-8 exerts a more direct effect on inflamma-
some function by directly associating with NLRP3. It seems
just as probable, however, that this association serves to regu-
late some function of caspase-8 by NLRP3.
DISCUSSION
Excessive activation of RIPK1 and RIPK3, either as a result of its
deficient restriction by caspase-8 or owing to other causes, trig-
gers in various tissues inflammatory processes that can have
severe pathological consequences (Ben Moshe et al., 2007;ecretion of TNF in response to LPS.
esponse to treatment with LPS. Unless otherwise indicated, in all ex-vivo
r the last 15 min of incubation. All ex-vivo assessments were done in triplicate
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Figure 4. Caspase-8 Deficiency in Dendritic Cells Facilitates IL-1b Generation by Promoting LPS-Induced Activation of the Inflammasome
(A–D) Cellular expression levels of IL-1bmRNA (A) and of the indicated proteins (B andC) and expression levels of themature form of IL-1b in the culturemedia (D)
of WT and C8 DCs stimulated with LPS or LPS +ATP. (WB, protein immunoblot.)
(E and F) Effect of knockdown of NLRP3 or ASC on generation of IL-1b in response to stimulation of WT and C8 DCs by LPS (E) or LPS+ATP (F).
(legend continued on next page)
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et al., 2009; Kovalenko et al., 2009; Mocarski et al., 2012; Smith
et al., 2007; Wallach et al., 2010; Zhang et al., 2009). Up to now,
the only known cellular consequence of activation of this func-
tional module was initiation of necrotic cell death. The inflicted
inflammation was therefore suggested to be a secondary event,
triggered via effects of damage-associated molecular patterns
(DAMPs) released by the dying cells. The findings of the present
study revealed that the ripoptosome can also signal for inflam-
mation in a more direct manner by triggering activation of the
NLRP3 inflammasome in DCs, thereby facilitating the generation
of proinflammatory cytokines such as IL-1b. Our preliminary data
indicate that ripoptosome activation also facilitates, in the same
manner, generation of IL-1b in macrophages.
Enhanced generation of IL-1b seems to contribute to the
increased vulnerability of mice with caspase-8-deficient DCs to
the lethal effect of LPS. In contrast, the severe skin inflammation
in mice with caspase-8-deficient epithelial cells was clearly
shown to occur independently of IL-1 (Kovalenko et al., 2009).
It remains to be clarified which of the various pathological conse-
quences of caspase-8 deficiency depend on IL-1, on other in-
flammasome effects, on necrotic cell death, or on other cellular
changes imposed by this deficiency.
Activation of the inflammasome in caspase-8-deficient DCs
was shown here to occur independently of necrotic cell death.
However, we found that it depends on expression of MLKL,
a protein kinase homolog associated with RIPK3, which was
previously shown to be required for the induction of necrosis.
Induction of both inflammasome activation and necrosis seems
also to involve PGAM5, a protein phosphatase activated by
RIPK3. Thus, even though it occurs independently of necrotic
cell death, induction of inflammasome activation in the cas-
pase-8-deficient DCs seems to involve several of the proximal
signaling proteins known to mediate induction of necrotic death.
Still, in view of our finding that LPS induced association of cas-
pase-8 with NLRP3, it seems possible that caspase-8 also
affects the assembly of the NLRP3 inflammasome by mecha-
nisms distinct from those by which it regulates necrotic death.
What mechanisms determine whether a cell will respond to
RIPK3 activation by induced assembly of the inflammasome,
by necrotic death, or in some other way? Our finding that
z-VAD renders caspase-8-deficient DCs vulnerable to the induc-
tion of necrosis suggests that this molecular decision is affected
by certain molecular targets of z-VAD other than caspase-8—
other caspases, or noncaspase enzymes such as lysosomal
cysteine proteases (Schotte et al., 1999)—whose function is
blocked by the inhibitory effect of z-VAD. These targets of
z-VAD action might affect the extent of ripoptosome assembly,
cell vulnerability to effector mechanisms activated by this
signaling, or both.
Not enough information is yet available, either on the mecha-
nisms of activation of the NLRP3 inflammasome or on the mech-
anisms of receptor-induced necrosis, to enable us to know(G) Levels of NLRP3 and ASC in the knocked-down cells.
(H) Protein immunoblot depicting effects of LPS, ATP, and Nec1 on NP40 solubi
(I) Protein immunoblot depicting association of the inflammasome components
crosslinking agent to it, followed by solubilization in SDS and immunoprecipitatiowhether the ripoptosome-induced effector mechanisms that
trigger the two processes are likely to be identical or to differ.
A number of authors have suggested that ROS might serve to
mediate both activation of the inflammasome and induction of
necrotic cell death. However, the evidence for ROS-mediated
activation of the NLRP3 inflammasome is controversial (re-
viewed in Franchi et al. [2012]; Mankan et al. [2012]), and
although necrotic cell death induction can indeed be blocked
by inhibitors of ROS in some cells, in other cells such inhibitors
have no effect (reviewed in Green et al. [2011]; Vandenabeele
et al. [2010]). Our tests failed to reveal a correlation between
ROS induction and induction of either inflammasome activation
or necrotic cell death in cultured DCs.
While initially identified as a component of the death-inducing
signaling complex activated by ligands of the TNF family, cas-
pase-8 is now known also to interact with a number of other
signaling complexes and thus serve a variety of different func-
tions. Some of its effects are even antagonistic in nature. Thus,
whereas—as shown here—activation of IL-1b by the NLRP3 in-
flammasome is restricted by caspase-8, the processing of IL-1b
triggered by the pathogen sensor dectin-1 or induced by
massive degradation of cIAP1 and cIAP2 is mediated by cas-
pase-8 (independently of caspase-1 [Gringhuis et al., 2012;
Vince et al., 2012]).
Notably, however, most of the known functions of caspase-8
seem to suppress, in one way or another, the activation of innate
immunity. Caspase-8 does this by dictating the cleavage of
signaling proteins that mediate proinflammatory gene activation
(e.g., Lin et al. [1999]; Ravi et al. [1998]), withholding signaling for
necrotic cell death (Holler et al., 2000; Oberst et al., 2011), re-
stricting signaling for IRF3 activation via the RIG-I complex
(Rajput et al., 2011), and, as shown here, restricting activation
of the NLRP3 inflammasome. Its signaling for massive caspase
activation through the extrinsic cell-death pathway and the
consequent apoptotic cell death also contribute to inhibition of
the innate immune response through immunosuppressive
effects of cell-surface components of the apoptotic cell (Fadok
et al., 2001).
What functional roles can be served by these heterogeneous
inhibitory effects of caspase-8 on innate immunity, and why
was caspase-8 endowed with such a variety of inhibitory
effects? Induction of apoptotic cell death by killer cells via the
caspase-8-initiated extrinsic cell-death pathway is a cost-effec-
tive way to eliminate pathogen-affected cells without imposing
massive changes on the surrounding tissue. However, some
pathogens have developed ways to fight off this defense mech-
anism by blocking activation of the extrinsic pathway (Brune,
2011; Stennicke et al., 2002; Tschopp et al., 1998). In such situ-
ations, the mechanisms through which caspase-8 deficiency
augments innate immunity may constitute a second barrier of
defense.
However, as evidenced by the severe pathological conse-
quences of caspase-8 deficiency in various transgenic mouselity of the inflammasome components in WT and C8 DCs.
within the NP40 insoluble residue, assessed by application of a reversible
n, as described in Experimental Procedures (HC, heavy chain).
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Figure 5. Enhancement of Inflammasome Activation by Caspase-8 Deficiency Does Not Reflect Increased Necrotic Cell Death or Generation
of Extracellular Activating Molecules
(A–D) Kinetics of (A and C) the secretion of IL-1b byWT and C8DCs and (B and D) death of these cells (assessed bymeasuring LDH release, staining of the cells
with Topro-3 [50 nm] and determining their loss of mitochondrial membrane potential) in response to LPS, LPS + the pan-caspase inhibitor z-VAD (20 mM), TNF
(legend continued on next page)
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detrimental. This highlights the importance of elucidating their
cellular impact and finding ways to restrain them pharmaceuti-
cally. Up to now, the pathological consequences of excessive
coactivation of RIPK1 and RIPK3 were thought to reflect activa-
tion of only one kind of cellular change, namely necrotic death.
Our finding that RIPK1 and RIPK3 can also signal for activation
of the NLRP3 inflammasome without causing cell death calls
for systematic analysis of other possible consequences of acti-
vation of these two protein kinases and of the ways in which
they contribute to immune defense and immune pathology.
EXPERIMENTAL PROCEDURES
Reagents, Antibodies, and Mice
The reagents, antibodies, and mice utilized in this study are described in
Supplemental Experimental Procedures.
In Vivo Experiments
All animal protocols were approved by the Ethical Care Committee of The
Weizmann Institute of Science. Necrostatin-1 (Nec1, 6.25 mg/kg) was injected
into the tail vein and IL-1 receptor antagonist (IL-1RA, 25 mg/kg) was injected
intraperitoneally (i.p.) 15 min prior to LPS challenge (5 mg/kg, i.p.). Anti-TNF
antibody (50 mg) was injected i.p., 1 hr prior to LPS challenge. D-galactosamine
(GalN, 800 mg/kg) was injected i.p. together with LPS (5 mg/kg). Flow cytomet-
ric analysis was performed as described (Kang et al., 2004) on cells derived
from the spleen and from the inguinal and axillary lymph nodes of eachmouse.
For analysis of myeloid cell and stromal cell populations, the spleens were di-
gested with collagenase D (0.2 mg/ml, Roche) and DNase I (50 IU/ml, Roche)
for 30 min.
Histology and Tunel Staining
Tissues were fixed in 10% phosphate-buffered formalin pH 7.4, embedded in
paraffin, cut into 4 mm sections, and stained with hematoxylin and eosin (H&E).
For the terminal deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL) assay, we used TMR Red, an in situ cell-death detection
kit (Roche Applied Science), according to the manufacturer’s instructions.
Cell Culture and Quantification of Cell Death-Related Cellular
Changes
The techniques used for cell culturing and for determination of cell viability, cell
permeabilization, cellular levels of ROS, ATP release, and for generation of
necrotic cells are described in Supplemental Experimental Procedures.
Real-Time PCR Analysis
The mRNAs of Il1b, Ifnb1, Ifit1, Ifi44, Cxcl10, Mlkl, Pgam5, and Casp8 in RNA
isolated from the DCs were quantified by means of the RNeasy kit (QIAGEN),(1,000 IU/ml) combined with the SMAC mimetic compound BV6 (1 mM) or TNF co
initiation of the experiment, and both remained present, together with TNF or LP
(E) Inflammasome assembly in response to the various inducers applied in the ex
into a detergent-insoluble compartment (middle lane), and the extent of its asso
response to treatment for the specified durations with the indicated agents, wer
(F) Generation of reactive oxygen species (ROS) by WT and C8 DCs in respon
depicted in (A)–(D). Rotenone (10 mM) was applied as a positive control. Left show
with elevated fluorescence intensity (over the range defined by the horizontal ba
(G) LPS-induced secretion of IL-1b byWT and C8DCs incubated in culture medi
to 1 3 106 cells in a final volume of 1 ml.
(H) Permeability to the fluorescent dye ethidium bromide, assessed in WT (red line
WT cells incubated for 15 min with and without ATP (green and magenta lines, r
(I) Release of ATP from WT and C8 DCs during their incubation for 3 hr with L
(200 mM, as in Piccini et al. [2008]).
(J) Secretion of IL-1b by 13 106WT or C8DCs in culture, or by amixture of 53 1
too small to be visible) stimulation for 3 hr by LPS.using Assays-on-Demand (Applied Biosystems) on an ABI7500 real-time PCR
system, and the results are presented as described (Kovalenko et al., 2009).
RNA Interference
DCs were plated in 24-well plates at a concentration of 1 3 106 cells/well and
transfected using an Amaxa Nucleofector kit (Amaxa) with 500 nmol of siRNA
duplex per well (Dharmacon, Thermo Scientific). After 48 hr, the cells were pro-
cessed for analysis.
Immunoprecipitation and Protein Immunoblots
Sodium dodecyl sulfate (SDS) cell extracts were prepared by boiling the cells
for 5 min in an SDS lysis buffer (1% SDS, 20 mM Tris, and 150 mM NaCl), fol-
lowed by sonication for 15 s.When directly analyzed, SDS-solubilized samples
were normalized for equal amounts of protein, as assessed by the BCA Protein
Assay kit (Thermo Scientific).
For analysis of coimmunoprecipitation, bone marrow-derived DCs were
lysed in Nonidet P-40 buffer (1% NP-40, 50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1 mM EDTA, and complete protease inhibitor cocktail) on ice for
15 min and the lysates were then precleared with protein G beads at 4C for
2 hr. The precleared lysates were incubated overnight with a primary antibody
at 4C, and the protein G beads were then added for 4 hr.
For immunoblot analyses, primary antibodies were detected by horseradish
peroxidase-conjugated anti-mouse or anti-rabbit Ig antibodies. Blots were
developed with the enhanced chemiluminescence SuperSignal West Pico or
SuperSignalWest Femto Chemiluminescent Substrate system (Thermo Scien-
tific) according to the manufacturer’s instructions.
Analysis of Protein Associations by Chemical Crosslinking and
Immunoprecipitation
Because inflammasome components associate in large aggregates that
cannot be solubilized with nonionic detergents and fall apart when treated
with ionic detergents, we had to apply a reversible chemical crosslinking
reagent to assess their interactions, as described in Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2012.09.015.
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Figure 6. Signaling Mechanisms Mediating Activation of the Inflammasome in LPS-Treated Dendritic Cells
(A–D, H, and I) Coimmunoprecipitation of the indicated proteins from detergent extracts ofWT and C8DCs (in C, D andH – justWT cells) treated with LPS or TNF
(1,000 IU/ml) for the indicated periods. BV6 and z-VADwere applied as in Figure 5. The samples analyzed in (H) are identical to those in (C), and those analyzed in
(I) are identical to those in (A). (LC, light chain.)
(E–G) Effects of knockdown of MLKL or PGAM5 in WT and C8 DCs on (E) death of cells in response to their treatment for 16 hr with LPS or LPS+z-VAD, and (F)
secretion of IL-1b in response to their treatment for 3 hr with LPS.
(G) Levels of MLKL and PGAM5 mRNA in the knocked-down cells.
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